At the news
? MIXEDIMPACT 5/10 8-K filed Aug 6, 2026 at 07:10 ET
Bausch + Lomb announced a board reshuffle at the request of its 87% owner Bausch Health, replacing four independent directors with four new appointees including Bausch Health's CEO. The company also reported Q2 revenue of $1.394B (+9% YoY) and reaffirmed its raised 2026 guidance. The board changes increase parent-company control and reduce board independence, while the financial results show solid top-line growth and a significant cash-flow improvement.
- Bausch Health (87% owner) requested and secured the appointment of four new directors, including its own CEO Thomas Appio, replacing four independent directors.
- Q2 revenue was $1.394B, up 9% reported and 8% constant-currency YoY.
- Net cash from operations improved from $32M in Q1 to $153M in Q2; adjusted CFO from $45M to $161M.
- Full-year 2026 guidance reaffirmed: revenue $5.440B–$5.540B, Adjusted EBITDA ex-Acquired IPR&D $1.025B–$1.075B.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access